当前位置:首页 - 行情中心 - 灵康药业(603669) - 财务分析 - 现金流量表

灵康药业

(603669)

  

流通市值:31.91亿  总市值:31.91亿
流通股本:7.12亿   总股本:7.12亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金69,321,072.75371,605,687.42256,887,980.39176,565,565.69
  收到其他与经营活动有关的现金4,643,390.2531,529,453.6421,602,442.419,825,375.06
  经营活动现金流入小计73,964,463403,135,141.06278,490,422.79196,390,940.75
  购买商品、接受劳务支付的现金55,829,571.63255,757,641.14200,079,495.71117,119,438.78
  支付给职工以及为职工支付的现金11,397,042.844,884,098.3135,762,503.9227,541,748.6
  支付的各项税费6,566,882.2515,241,611.7213,202,906.9412,307,224.88
  支付其他与经营活动有关的现金29,404,665.42220,116,875.65147,498,149.1378,382,437.39
  经营活动现金流出小计103,198,162.1536,000,226.82396,543,055.7235,350,849.65
  经营活动产生的现金流量净额-29,233,699.1-132,865,085.76-118,052,632.91-38,959,908.9
二、投资活动产生的现金流量:
  收回投资收到的现金-9,697,845.189,689,834.219,689,834.21
  取得投资收益收到的现金-1,105,526.311,114,006.211,114,006.21
  处置固定资产、无形资产和其他长期资产收回的现金净额100,0007,008,973.979,457,504.85191,000
  收到的其他与投资活动有关的现金-17,332,76217,332,76217,332,762
  投资活动现金流入小计100,00035,145,107.4637,594,107.2728,327,602.42
  购建固定资产、无形资产和其他长期资产支付的现金1,921,1602,683,196.081,024,744.02825,650.02
  投资活动现金流出小计1,921,1602,683,196.081,024,744.02825,650.02
  投资活动产生的现金流量净额-1,821,16032,461,911.3836,569,363.2527,501,952.4
三、筹资活动产生的现金流量:
  取得借款收到的现金20,000,00015,000,0005,000,000-
  收到其他与筹资活动有关的现金1,713.45250,000,000252,008,404.39252,008,404.39
  筹资活动现金流入小计20,001,713.45265,000,000257,008,404.39252,008,404.39
  偿还债务支付的现金--1,008.251,008.25
  分配股利、利润或偿付利息支付的现金130,722.236,591,341.08--
  支付其他与筹资活动有关的现金-252,067,443.33250,000,000250,000,000
  筹资活动现金流出小计130,722.23258,658,784.41250,001,008.25250,001,008.25
  筹资活动产生的现金流量净额19,870,991.226,341,215.597,007,396.142,007,396.14
五、现金及现金等价物净增加额-11,183,867.88-94,061,958.79-74,475,873.52-9,450,560.36
  加:期初现金及现金等价物余额153,207,461.73247,269,420.52247,269,420.52247,269,420.52
  期末现金及现金等价物余额142,023,593.85153,207,461.73172,793,547237,818,860.16
补充资料:
  净利润--193,239,351.39--35,733,685.77
  资产减值准备-41,449,843.73-107,822.6
  固定资产和投资性房地产折旧-23,805,420.43-11,781,614.91
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-23,805,420.43-11,781,614.91
  无形资产摊销-7,260,712.26-3,438,427.45
  长期待摊费用摊销-3,505,953.31-1,443,838.73
  处置固定资产、无形资产和其他长期资产的损失--3,533,141.93-49,322.73
  固定资产报废损失-818,869.01-206,027.62
  公允价值变动损失-570,782.06-347,222.93
  财务费用-21,197,524.07-10,272,529.67
  投资损失-2,407,842.88-3,046,508.71
  递延所得税--465,067.31--232,533.66
    递延所得税负债增加--465,067.31--232,533.66
  存货的减少--59,641,231.71--21,021,707.83
  经营性应收项目的减少-6,317,605.54-1,751,629.05
  经营性应付项目的增加--26,007,310.57--19,273,933.27
  其他-41,741,183.73--70,978.48
  现金的期末余额-153,207,461.73-237,818,860.16
  减:现金的期初余额-247,269,420.52-247,269,420.52
  现金及现金等价物的净增加额--94,061,958.79--9,450,560.36
公告日期2026-04-292026-04-292025-10-312025-08-23
审计意见(境内)标准无保留意见
TOP↑